Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099879 · ClinicalTrials.gov registry record · Phase 2
Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
A Phase 2 study, sponsored by Bristol-Myers Squibb.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00099879: Clinical Trial Phase 2 study, sponsored by Bristol-Myers Squibb.
NCT00099879 is a Phase 2 study that was terminated before completion, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00099879, a Phase 2 study, was terminated before completion, sponsored by Bristol-Myers Squibb.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.
Interventions
- DRUG BMS-275183
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 2 |
Why NCT00099879 stopped before completion
NCT00099879 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which BMS-275183 is the first listed.
NCT00099879 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00099879 about?
NCT00099879 is a clinical study titled "Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer". The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.
What is the current status of trial NCT00099879?
This trial is currently terminated. It is a Phase 2 study.
What interventions are being tested in trial NCT00099879?
The interventions under investigation include: BMS-275183 (DRUG).
Who is sponsoring clinical trial NCT00099879?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.